Healthcare Finance News September 16, 2021
The report received harsh criticism from advocacy group 340B Health, which called the methodology highly flawed.
Certain safety net hospitals are charging insurers an average of 3.8 times more than the acquisition costs for oncology drugs, although depending on the drug, the markup can be much higher — up to 11 times the purchase price, a new report has found.
Founded in 1992, 340B is a federal program that requires drug manufacturers to provide outpatient drugs at significantly reduced prices to eligible healthcare organizations that are supposed to treat high numbers of uninsured and low-income patients. Hospitals claim the savings are used to reduce the price of drugs for patients and expand health services, but the report claims the discounts...
Today's Sponsors
Today's Sponsor